Renapurkar Shravan Kumar, Laskin Daniel M
Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University, 520 North 12th Street, Wood Building Room 311C, Richmond, VA 23298, USA.
Department of Oral and Maxillofacial Surgery, Virginia Commonwealth University, 520 North 12th Street, Wood Building Room 311C, Richmond, VA 23298, USA.
Oral Maxillofac Surg Clin North Am. 2018 Aug;30(3):343-349. doi: 10.1016/j.coms.2018.04.009. Epub 2018 Jun 1.
Recurrent temporomandibular joint dislocation (TMJD) is a distressing entity to the patient and a therapeutic challenge to the treating provider. Absence of high-level evidence in literature among currently available treatment options creates a lack of consistency in management. This article reviews the current literature on common injectable agents used and the open surgical techniques. Based on the findings, an injectable agent is the initial treatment of choice for recurrent TMJD, with capsulorraphy and eminectomy being used in nonresponding patients.
复发性颞下颌关节脱位（TMJD）对患者来说是一种痛苦的病症，对治疗医生而言也是一项治疗挑战。目前可用的治疗方案中缺乏高水平的文献证据，导致治疗管理缺乏一致性。本文综述了有关常用注射剂和开放性手术技术的当前文献。基于这些发现，注射剂是复发性TMJD的首选初始治疗方法，对于无反应的患者则采用关节囊缝合术和髁突切除术。
